The first photodynamic drug with anti-metastatic activities

Researchers at the University of Zurich have devised and successfully tested the first potential anticancer drug which has excellent properties as a photodynamic therapy (PDT) agent as well as potential anti-metastatic activities in vivo. Namely, this new agent destroys melanoma skin cancer cells and blocks the spread of the cancer to other sites in the… »